KMDA · Insider Trading
Kamada Ltd
Every open-market purchase and sale reported by KMDA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Ishay Davidi | Director | A | +86,500 deriv. | — |
| 2026-09-29 | Uri Botzer | Director | A | +60,000 deriv. | — |
| 2026-09-29 | Lilach Asher-Topilsky | Director | A | +86,500 deriv. | — |
| 2026-09-25 | Amir London | Chief Executive Officer | A | +800,000 deriv. | — |
| 2026-09-24 | Shavit Beladev | VP Plasma Operations | A | +75,000 deriv. | — |
| 2026-09-24 | Lilach Payorski | Director | A | +60,000 deriv. | — |
| 2026-09-24 | Boris Gorelik | VP, BD and Strategic Programs | A | +15,000 deriv. | — |
| 2026-09-24 | Karnit Goldwasser | Director | A | +86,500 deriv. | — |
| 2026-09-24 | Liron Reshef | VP Human Resources | A | +100,000 deriv. | — |
| 2026-09-23 | Yael Brenner | VP Quality | A | +60,000 deriv. | — |
| 2026-09-23 | Nir Livneh | VP, General Counsel | A | +89,485 deriv. | — |
| 2026-09-23 | Eran Nir | VP, Operations | A | +112,500 deriv. | — |
| 2026-09-23 | David Tsur | Director | A | +37,500 deriv. | — |
| 2026-09-23 | Leon Recanati | Director | A | +86,500 deriv. | — |
| 2026-09-23 | Assaf Itshayek | Director | A | +46,000 deriv. | — |
| 2026-09-23 | Chaime Orlev | Chief Financial Officer | A | +202,500 deriv. | — |
| 2026-09-23 | Hanni Neheman | VP, Marketing & Sales | A | +75,000 deriv. | — |
| 2026-09-23 | Orit Pinchuk | VP Regulatory Affairs | A | +75,000 deriv. | — |
| 2026-09-23 | Benjamin Dekel | Director | A | +46,000 deriv. | — |
| 2026-09-17 | Nir Livneh | VP, General Counsel | MIXED | +6,541 | +$24.82K |
| 2026-09-17 | Yael Brenner | VP Quality | MIXED | +9,569 | +$38.79K |
| 2026-09-17 | David Tsur | Director | Sell | −22,827 | −$186.72K |
| 2026-09-11 | David Tsur | Director | Sell | −177,173 | −$1.46M |
| 2026-09-08 | Yael Brenner | VP Quality | MIXED | +2,171 | +$10.79K |
| 2026-09-08 | David Tsur | Director | MIXED | +39,834 | +$252.87K |
| 2026-08-31 | Yael Brenner | VP Quality | MIXED | +7,224 | +$38.68K |
| 2026-08-06 | Lilach Asher-Topilsky | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Ishay Davidi | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Leon Recanati | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Benjamin Dekel | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Assaf Itshayek | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Lilach Payorski | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Karnit Goldwasser | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Uri Botzer | Director | A | +30,000 deriv. | — |
| 2026-08-06 | David Tsur | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Assaf Itshayek | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Karnit Goldwasser | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Leon Recanati | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Uri Botzer | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Benjamin Dekel | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Ishay Davidi | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Lilach Asher-Topilsky | Director | A | +30,000 deriv. | — |
| 2026-08-06 | Lilach Payorski | Director | A | +30,000 deriv. | — |
| 2026-08-06 | David Tsur | Director | A | +30,000 deriv. | — |
| 2026-04-09 | Benjamin Dekel | Director | MIXED | — | — |
| 2026-04-09 | Assaf Itshayek | Director | MIXED | — | — |
| 2026-04-09 | Yael Brenner | VP Quality | MIXED | — | — |
| 2026-04-09 | Nir Livneh | VP, General Counsel | MIXED | — | — |
| 2026-04-09 | Orit Pinchuk | VP Regulatory Affairs | MIXED | — | — |
| 2026-04-09 | Lilach Payorski | Director | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| David Tsur | Director | 407,929 | $3.30M |
| Yael Brenner | VP Quality | 6,266 | $50.63K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KMDA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.